4//SEC Filing
Sundaram Senthil Vel 4
Accession 0001209191-19-039818
CIK 0001636050other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 6:06 PM ET
Size
6.0 KB
Accession
0001209191-19-039818
Insider Transaction Report
Form 4
Sundaram Senthil Vel
Director
Transactions
- Award
Stock Option ( Right to Buy)
2019-06-27+18,750→ 18,750 totalExercise: $6.19Exp: 2029-06-26→ Common Shares (18,750 underlying)
Footnotes (1)
- [F1]The common shares underlying this option vest over a period of three years, with one-third of the common shares vesting on each of the first, second and third anniversaries of June 27, 2019, the date of the Reporting Person's appointment to the Issuer's Board of Directors. The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares. All common shares underlying such option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan.
Documents
Issuer
Axovant Gene Therapies Ltd.
CIK 0001636050
Entity typeother
Related Parties
1- filerCIK 0001762316
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 6:06 PM ET
- Size
- 6.0 KB